GlassScriptPhysician profile
Cameron Taylor Kluth
NPI 1508245515
$22,323.69
in general payments reported to CMS, 2019-2025
30 companies · $1,959 in 2025
The $1,959 reported for 2025 was more than what 78% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $210 · 2021: $890 · 2022: $990 · 2023: $1,621 · 2024: $947 · 2025: $1,959.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,145 · Travel and Lodging: $289 · Education: $92.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,145.20 |
| Travel and Lodging | $289.38 |
| Education | $92.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $15,000.00 | 2019 | |
| Medtronic, INC. | $1,734.04 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Synchromedii |
| Boston Scientific Corporation | $1,157.40 | 2019-2025 | General - Pain Management, Wavewriter Alpha Prime 16, Clik X |
| Nevro Corp. | $1,120.89 | 2020-2024 | Senza |
| Curonix LLC | $861.13 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Collegium Pharmaceutical, INC. | $346.25 | 2020-2025 | Belbuca, Xtampza |
| Biotronik Nro, INC. | $307.59 | 2025 | Prospera |
| Abbott Laboratories | $249.95 | 2021-2025 | Proclaim, Ionicrf |
| Scilex Pharmaceuticals INC. | $234.33 | 2020-2023 | Ztlido |
| Vertos Medical, INC. | $160.61 | 2021-2024 | Mild Device Kit |
| Grt US Holding, INC. | $155.93 | 2022 | |
| Saluda Medical Americas, INC. | $109.85 | 2024-2025 | Evoke |
| Foundation Fusion Solutions, LLC | $108.70 | 2024-2025 | |
| Abbvie INC. | $103.44 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $99.18 | 2021-2025 | Relistor |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Valinor Pharma, LLC | $72.56 | 2025 | Movantik |
| Bioventus LLC | $68.29 | 2022-2025 | Durolane, Durolane |
| Tersera Therapeutics LLC | $53.06 | 2025 | Prialt |
| Amgen INC. | $46.26 | 2021-2022 | |
| Stryker Corporation | $45.59 | 2025 | Mild Device Kit |
| Averitas Pharma INC. | $43.49 | 2025 | Qutenza |
| Hikma Pharmaceuticals USA | $38.44 | 2022 | |
| Biodelivery Sciences International, INC. | $38.30 | 2020-2021 | |
| Spr Therapeutics, INC | $34.29 | 2025 | Sprint Pns System |
| Globus Medical, INC. | $33.11 | 2025 | Senza |
| Nalu Medical, INC. | $29.64 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $22.65 | 2025 | |
| Innovation Technologies INC | $17.38 | 2025 | Irrisept |
| Depuy Synthes Sales INC. | $17.18 | 2024 | Monovisc, Orthovisc |
| Si-Bone, INC. | $14.16 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cameron Kluth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.